Skip to main content
Signal8

Bergmann Joshua Benjamin

SEC insider (Form 3/4/5 filer). CIK 0002131863. GC and Corporate Secretary at GYRE THERAPEUTICS, INC. (GYRE). 1 reported Form 4/5 transaction since Sep 2024; latest on Jun 8, 2026. Located in SAN DIEGO, CA.

Companies Bergmann Joshua Benjamin has filed insider reports for

  • GYRE THERAPEUTICS, INC. (GYRE): Officer, GC and Corporate Secretary
Bergmann Joshua Benjamin profile photo

Bergmann Joshua Benjamin

CIK: 0002131863

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GYRE THERAPEUTICS, INC. logo
GYRE

GYRE THERAPEUTICS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • GYRE THERAPEUTICS, INC. logo
    GYRE

    GYRE THERAPEUTICS, INC.

    Jun 8, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    50K shares-

1-1 of 1